GP30101

· Geropharm

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GP30101, covering 2024-07-22 to 2024-07-22. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of GP30101 800 mg (GEROPHARM) Versus PREZISTA® 800 mg ("Jonson&Jonson", Russia) [NA]